Lijinsky W, Kovatch R M, Thomas B J
ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, MD 21702.
Carcinogenesis. 1992 Jul;13(7):1293-7. doi: 10.1093/carcin/13.7.1293.
The carcinogenic effects of combinations of methapyrilene hydrochloride (MP), nitrosodiethylamine (NDEA), and phenobarbital (PB) or partial hepatectomy (PH) were examined following sequential treatment of rats. MP is a generally non-genotoxic liver carcinogen of moderate potency, NDEA is a genotoxic liver carcinogen, PB is primarily a liver tumor promoter and PH induces cell proliferation. The dose of each carcinogen was chosen to be below that causing significant liver tumor incidence when given singly. There were 12 protocols involving groups of 28 female rats each. Short treatments with NDEA and MP were followed by 60 weeks of PB promotion or by partial hepatectomy. Each treatment was given separately or in double combination as controls. Several animals of each group were killed at intervals during the experiment for examination of toxic effects and the presence of altered hepatic foci. In only 3 of 12 groups was there a significant incidence of rats with liver neoplasms: the two groups given three treatments: NDEA, MP and PB (86% tumors) or NDEA, MP and PH (33%), and the group receiving NDEA and MP without promotion (46%). The results clearly indicated a co-carcinogenic effect between NDEA and MP. Continuous PB potentiated tumor development, while PH did not. There was no evidence of liver toxicity from any of the treatments, but clear cell foci observed in three groups at weeks 13 and 33 correlated with the later development of liver neoplasms.
在对大鼠进行序贯治疗后,研究了盐酸美吡拉敏(MP)、二乙基亚硝胺(NDEA)与苯巴比妥(PB)组合或部分肝切除术(PH)的致癌作用。MP是一种一般无遗传毒性、致癌效力中等的肝致癌物,NDEA是一种具有遗传毒性的肝致癌物,PB主要是一种肝肿瘤促进剂,而PH可诱导细胞增殖。每种致癌物的剂量选择为单独给药时导致显著肝肿瘤发生率的剂量以下。共有12种方案,每组有28只雌性大鼠。先用NDEA和MP进行短期治疗,然后进行60周的PB促进或部分肝切除术。每种治疗分别给予或作为对照进行双重组合。在实验期间每隔一段时间处死每组的几只动物,以检查毒性作用和肝灶性病变的存在情况。在12组中只有3组出现肝肿瘤大鼠的显著发生率:两组接受三种治疗:NDEA、MP和PB(86%发生肿瘤)或NDEA、MP和PH(33%),以及未进行促进处理而接受NDEA和MP的组(46%)。结果清楚地表明NDEA和MP之间存在协同致癌作用。持续给予PB可增强肿瘤发展,而PH则无此作用。没有证据表明任何一种治疗会导致肝毒性,但在第13周和第33周在三组中观察到的透明细胞灶与后来肝肿瘤的发生相关。